Tag: diabetes


Accra, Ghana – The number of diabetes cases and the associated health care budget has been increasing worldwide. It has thus become a growing public health burden for patients, health care providers, and society. The cost of diabetes study has

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , , , ,

What Does the Future of Health Technology Assessment Hold for Mainland China, Japan, South Korea, and Taiwan?

Indianapolis, IN, USA – Diabetes mellitus (DM) is associated with significant economic and humanistic burden. The condition presents a real challenge in Asia, which accounts for more than 60% of individuals with DM, globally.

Posted in Value in Health Regional Issues Tagged with: , , , , ,

Potential Common Benchmark For Assessing New Diabetes Treatments

Basel, Switzerland – Many new products for type 2 diabetes mellitus (T2DM) will be launched in the coming years as a response to this ever-increasing world epidemic. Health technology assessment (HTA) agencies require cost-effectiveness studies of these agents, but no consistent

Posted in Systematic Reviews, Value in Health Tagged with: , , , ,

Drug Initiation: Major Issue In Long-Term Adherence To Medication Therapy

Gentofte, Denmark – Poor adherence to long-term medication therapy among patients with a chronic disease is well-known, but the nature of poor adherence over time, at a population level is not well established. Studies from clinical trials have shown that discontinuation is

Posted in Methodological Articles, Value in Health Tagged with: , ,

Can Pharmaceutical Care Interventions Improve Type 2 Diabetes Management?

Enugu State, Nigeria – Cost-utility analysis was developed to help decision makers compare the values of alternative interventions. With the increasing demand for better management of type 2 diabetes, attention has been focused on the potential benefits of pharmaceutical care (PC)

Posted in Value in Health Regional Issues Tagged with: , , ,